|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
C3J Therapeutics, Inc.
| | | Phone: | (310) 665-2928 | Fax: | (310) 665-2963 | Year Established: | 2005 | Main Contact: | Brian Varnum, Ph.D., Chief Development Officer | | Other Contacts: | Wenyuan Shi, Ph..D, Founding Scientist David Goesling, MBA, VP, Finance & Accounting Todd Patrick, MBA, President & CEO Duane Morris, BA, VP, Production & Facilities
| | Company Description | C3J Therapeutics is a clinical stage biotechnology company focused on improving human health through the development and commercialization of targeted, pathogen-specific antimicrobials (STAMPs) that treat and prevent human diseases caused by microbial dysbiosis. The proprietary STAMP platform technology has potential applications to a variety of bacterial infections, and disorders, particularly related to the human microbiome. In addition to a Phase 2 program for dental caries, C3J anticipates advancing a C. difficile STAMP into the clinic in 2017. | |
|
|
|
|
|